Sugar-Induced Modification of Fibroblast Growth Factor 2 Reduces Its Angiogenic Activity in Vivo
- 31 August 2002
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (2) , 531-541
- https://doi.org/10.1016/s0002-9440(10)64209-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Acidosis Inhibits Endothelial Cell Apoptosis and Function and Induces Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor ExpressionCirculation Research, 2000
- Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylationBiochemical Journal, 1999
- Rescue of Diabetes-Related Impairment of Angiogenesis by Intramuscular Gene Therapy with Adeno-VEGFThe American Journal of Pathology, 1999
- Identification of a β-lactoglobulin lactosylation siteBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1998
- Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.Journal of Clinical Investigation, 1997
- Effect of Galactose on α-CrystallinOphthalmic Research, 1996
- Microvascular function in human diabetes. A physiological perspectiveDiabetes, 1995
- Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.Journal of Clinical Investigation, 1994
- Accumulation of Maillard reaction products in skin collagen in diabetes and aging.Journal of Clinical Investigation, 1993
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988